Skip to content
Warrant Exercise

Xintela AB

Xintela is a biomedical company working in the fields of stem cell therapy and targeted cancer therapy, with focus on indications with a high unmet medical need.

Summary

To subscribe for one (1) new share at the subscription price of 0.30 SEK per share one (1) warrant TO 3 is needed. For subscription with warrants on a VP-account, the below subscription form can be used. If your warrants is in a nominee account at a bank you need to subscibe through the bank where your warrants is located.

Subscription period
November 25 – December 5, 2024
Subscription price
SEK 0.30 per share

Warrant exercise TO 3

Issuing Agent

November 2024
Skip to navigation